UBS Group’s Aimei Health Technology Co AFJK Stock Holding History

UBS Group’s Portfolio AFJK Stock Details AFJK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$343	Sell	14 -1,300	-99%	-$57.2K	﹤0.01%	9938
2025 Q4	$84.1K	Sell	1,314 -2,643	-67%	-$57.6K	﹤0.01%	6996
2025 Q3	$44.8K	Sell	3,957 -344	-8%	-$3.87K	﹤0.01%	7639
2025 Q2	$47.6K	Buy	4,301 +1	+0%	+$11	﹤0.01%	7815
2025 Q1	$47.3K	Hold	4,300	–	–	﹤0.01%	7639
2024 Q4	$46K	Buy	+4,300	New	+$45.5K	﹤0.01%	7353
2024 Q3	–	Sell	-1,205	Closed	-$12.5K	–	9453
2024 Q2	$12.5K	Buy	1,205 +1,171	+3,444%	+$12.1K	﹤0.01%	7598
2024 Q1	$347	Buy	+34	New	+$346	﹤0.01%	8616

Other funds holding AFJK

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group's AFJK Position: Q1 2026 in Review

UBS Group reduced its Aimei Health Technology Co (AFJK) stake by 99% in Q1 2026, selling an estimated $57.2K and leaving 14 shares worth $343. The position accounts for ﹤0.01% of the portfolio, ranked #9938.

UBS Group first reported a position in AFJK in Q1 2024 and has held it in 8 quarters since. The position peaked at $84.1K in Q4 2025. 8 funds tracked by Wall St. Rank hold AFJK as of Q1 2026.

UBS Group held 14 shares of Aimei Health Technology Co worth $343 as of Q1 2026.
UBS Group sold 1,300 Aimei Health Technology Co shares in Q1 2026, an estimated $57.2K.
Aimei Health Technology Co made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9938 holding.
UBS Group first reported a position in Aimei Health Technology Co in Q1 2024 and has held it in 8 quarters since.
UBS Group's Aimei Health Technology Co position peaked at $84.1K in Q4 2025.
8 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.